Value for money in the English NHS: summary of the evidence by Martin, S. et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
Value for Money in the English NHS: 
Summary of the Evidence 
 
 
 
 
 
 
 
 
 
CHE Research Paper 18 
 
  
 
 
 
 
 
 
Value for money in the English NHS: Summary 
of the evidence 
 
 
 
Stephen Martin * 
Peter C Smith ** 
Sheila Leatherman *** 
 
 
 
 
 
 
 
 
 
*Department of Economics, University of York 
**Centre for Health Economics, University of York 
*** School of Public Health, University of North Carolina  
 
 
 
 
 
 
 
 
July 2006 
 
Background 
 
CHE Discussion Papers (DPs) began publication in 1983 as a means of making current 
research material more widely available to health economists and other potential users.  So 
as to speed up the dissemination process, papers were originally published by CHE and 
distributed by post to a worldwide readership.  
 
The new CHE Research Paper series takes over that function and provides access to current 
research output  via web-based publication, although hard copy will continue to be available 
(but subject to charge). 
 
Acknowledgements 
 
This study was undertaken as part of the Quest for Quality and Improved Performance, a five-
year initiative of The Health Foundation.  Unless stated otherwise, all of the data cited in the 
text refer to England rather than the United Kingdom. 
 
Disclaimer 
 
Papers published in the CHE Research Paper (RP) series are intended as a contribution to 
current research. Work and ideas reported in RPs may not always represent the final position 
and as such may sometimes need to be treated as work in progress. The material and views 
expressed in RPs are solely those of the authors and should not be interpreted as 
representing the collective views of CHE research staff or their research funders. 
 
 
Further copies 
 
Copies of this paper are freely available to download from the CHE website 
http://www.york.ac.uk/inst/che/publications/publications.htm. Access to downloaded material 
is provided on the understanding that it is intended for personal use. Copies of downloaded 
papers may be distributed to third-parties subject to the proviso that the CHE publication 
source is properly acknowledged and that such distribution is not subject to any payment. 
 
Printed copies are available on request at a charge of £5.00 per copy. Please contact the 
CHE Publications Office, email che-pub@york.ac.uk, telephone 01904 321458 for further 
details. 
 
 
Centre for Health Economics 
Alcuin College 
University of York 
York, UK 
www.york.ac.uk/inst/che 
 
 
 
 
 
 
 
 
 
Value for money in the English NHS: summary of the evidence       
Contents 
 
Abstract 
  
  
1. Introduction          1 
 
 
2. NHS expenditure, inputs and activity levels      2 
 
 2.1 How much expenditure growth?       2 
 2.2 Input growth         3 
 2.3 Activity growth          5 
  2.3.1 Units of service        5 
  2.3.2 Drug spending        5 
  2.3.3 Clinical outcomes        6 
  2.3.4 Access         7 
  2.3.5 Patient experience       8 
 
 
3. Where is the expenditure growth going?      9 
 
3.1 Main categories of growth       9 
3.2 Department of Health estimates       9 
3.3 Interpretation of expenditure growth      10 
 
 
4. NHS productivity change        13 
 
 4.1 Productivity measurement before June 2004     13 
 4.2 Developments in NHS productivity measurement since June 2004  14 
  4.2.1 Measuring the volume of NHS inputs     14 
  4.2.2 Output without quality adjustments     15 
  4.2.3 Output with quality adjustments      17 
  4.2.4 Post-June 2004 NHS productivity estimates    18 
 4.3 Summary         19 
 
 
5. Conclusion          21 
 
 
References           23 
 
 
CHE Research Paper 18 
Abstract 
 
The extent to which the English National Health Service secures value for money for taxpayers has 
become a central issue of political and public debate. Questions include: how much expenditure growth 
has been made available to the NHS? on what has that money been spent? what improvements in the 
volume and quality of health care have been secured? and what are the implications for productivity? 
There has been a flurry of research activity designed to address these and similar questions. This report 
seeks to bring together this research in a concise format and draws some tentative conclusions about 
recent productivity changes in the NHS. 
 
It finds that there is considerable evidence of growth in both the volume and quality of NHS activity. 
However, this has not in general kept pace with the growth in expenditure. On most measures, therefore, 
NHS productivity is either static or declining. However, the report highlights a large number of 
unresolved methodological issues that make it hard to draw any definitive conclusions. We conclude 
that the measurement of NHS productivity change makes an important contribution to national debate. 
However, there remains considerable scope for improving both the data and the methods underlying 
current estimates. 
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1. Introduction 
 
In 1997-98 the Labour Government set out to “modernise the NHS” (DH, 1997). A wide-ranging set of 
reforms has been put into place which has been described as the most ambitious and comprehensive 
effort to improve the quality of health care of any country (Leatherman and Sutherland, 2003). However, 
recognising that a factor in the underperformance of the NHS was historical underfunding, in January 
2000 Tony Blair committed his Government to matching European levels of spending on health care.  At 
that time the UK spent 7.3% of GDP on health care.  By 2008 this proportion is set to reach 9.4% and 
this is expected to be broadly comparable with other European countries (Oliver, 2005, pS80).  Between 
2000 and 2008, NHS expenditure is set to increase by over 10% per annum in real terms (that is, 
relative to the GDP deflator).  This can be contrasted with the period from 1992 to 2000 when the 
average annual real increase was just over 3% (relative to the GDP deflator). 
 
These large funding increases were expected to deliver correspondingly large service improvements, 
and the NHS Plan was designed to secure these (DH: 2000a and 2000b).  Several studies have sought 
to evaluate whether these funding increases have delivered the expected gains in the form of 
improvements in health status and increased public satisfaction.  Such studies have typically used 
several indicators – such as waiting times, cancer survival rates, and heart disease death rates – to 
evaluate whether the desired performance improvements have been forthcoming (see, for example, 
Bosanquet et al (2005), King’s Fund (2005), NHS Confederation (2005)).  At the same time the Atkinson 
Report (2005), on the measurement of government output and productivity for the National Accounts, 
has encouraged the DH and ONS to devise and apply new methods of measuring NHS output and 
productivity growth.  In contrast to the other studies cited above, measuring NHS output for the National 
Accounts leads to a ‘single number’ measure of the output of a large and complex system.   
 
This paper provides an assessment of the recent performance of the NHS and highlights some of the 
challenges involved in coming to a definitive conclusion regarding value for money.  Section 2 provides 
some conventionally reported metrics   of recent trends in NHS expenditure, labour and capital inputs, 
and activity levels.  Section 3 presents some details about where the extra NHS funding has been spent 
and, in particular, partitions the extra funding between that used to: (a) meet increased costs for existing 
employees and NHS wage rates; (b) fund additional ( newly hired) NHS staff; and (c) to buy extra 
activity.  Although this split makes apparent sense, attaching an interpretation to, say, the extra cash 
allocated to the NHS wage bill is not straightforward: for example, is the infusion of funds attracting and 
retaining a more highly skilled workforce or is it merely an unproductive outflow of funds to employees? 
 
Section 4 summarises several recent studies that have sought to incorporate the information presented 
in sections 2 and 3 – together with a much wider body of material on NHS inputs and outputs – into a 
study of NHS productivity.  In theory, a productivity measure will provide a single number estimate of the 
performance of the NHS.  Recent work in estimating system productivity has developed innovative 
approaches, such as seeking to incorporate measures of quality alongside measures of inputs and 
activity.  However, because of the difficulties associated with defining and measuring quality, little 
consensus has yet to emerge as to the ‘correct’ or most appropriate approach.  The ONS has presented 
a range of estimates that reflect different assumptions and different methods, and their relative merits 
are discussed. 
 
Value for money currently is a popular topic for study, so we shall be covering some ground that others 
have already visited (for example, King’s Fund (2005)).  Where applicable, we have noted the 
conclusions reached by other studies.  It should also be noted that, in addition to the ‘single number’ 
NHS productivity measure of performance, several studies have employed a variety of performance 
indicators – such as waiting times, mortality rates, and patient satisfaction surveys – to assess the 
recent performance of the NHS.  These performance indicators are not considered in any depth here 
although they are mentioned briefly when discussing NHS activity levels in section 2. 
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2. NHS expenditure, inputs and activity levels 
 
This section provides an overview of recent changes in NHS expenditure, input, and activity levels.  It is 
not intended to be comprehensive but rather to illuminate some recent developments in the NHS and 
provide some context for policy debates. 
 
2.1 How much expenditure growth? 
 
Table 1 shows net NHS expenditure at current prices, constant GDP prices, and constant NHS prices.  
At current prices, expenditure is planned to increase from over £26 billion in 1991/92 to just under £93 
billion in 2007/08.  This current price expenditure series can be deflated to a constant price basis by 
using an appropriate price index.  Two such indices are shown in Table 1.  One price index - the GDP 
deflator - reflects the price of goods and services throughout the entire UK economy while the other - the 
NHS pay and prices index - reflects the cost of goods and services purchased by the NHS.  Between 
1991 and 2004 the GDP deflator increased by 40% but the NHS pay and price index rose by 70%.  In 
other words, the cost of goods and services purchased by the NHS increased by considerably more 
than the price of goods and services across the entire UK economy.  One implication of this divergence 
between the GDP deflator and the NHS pay and prices index is that deflation of the cash sum available 
to the NHS by the GDP deflator will exaggerate the real volume of resources available to the NHS. 
 
At constant GDP prices, NHS expenditure increased by about 3% per annum between 1991/92 and 
1999/00 and is planned to increase by about 10% annually thereafter until 2007/08.  However, deflating 
NHS expenditure by the NHS pay and prices index reveals that the real terms increase between 
1991/92 and 1999/00 was 2% per annum, and is planned to be about 7% per annum thereafter until 
2007/08.  The NHS pay and prices index will reflect NHS pay bargaining over which the NHS has 
considerable control, and so there is some question as to whether it is entirely appropriate as a measure 
of the inescapable price rises experienced by the NHS.  This issue is discussed further in section 3. 
 
Table 1 NHS expenditure in current and constant prices, 1991/92 - 2007/08, England. Current 
prices reflect the cash paid in the year in question, constant prices show the expenditure 
adjusted by an index of price change. 
 
Year NHS spend, 
current prices,  
£ million 
GDP deflator 
index 
1991/92=100 
NHS spend, 
constant GDP 
prices, £ million 
NHS Pay and 
prices index 
1991/92=100 
NHS spend, 
constant NHS 
prices, £ million 
1991/92 26317 100 26317 100 26317 
1992/93 29072 104 27955 107 27066 
1993/94 30082 107 28159 111 27054 
1994/95 31774 109 29283 114 27833 
1995/96 33245 111 29859 119 27957 
1996/97 34297 115 29837 122 28045 
1997/98 36029 118 30456 124 28961 
1998/99 38050 122 31278 130 29362 
1999/00 41452 124 33333 136 30547 
2000/01 45299 126 35943 142 31980 
2001/02 50547 129 39224 149 33865 
2002/03 55724 133 41901 155 35990 
2003/04 63001 137 45905 164 38452 
2004/05 69710 140 49729 170 41036 
2005/06 76388 144 53059 177 43154 
2006/07 84324 148 56875 185 45619 
2007/08 92643 152 60929 193 47909 
Sources: OHE Compendium of Health Statistics for UK GDP and NHS deflators; DH annual Departmental Report, various 
issues,for NHS expenditure.1  Figures for 2005/06 onwards are based on estimates/plans.  
 
 
 
                                                 
1 More precisely, current expenditure on Stage 2 resource budgeting terms from 2002/03, on Stage 1 terms from 1999/00 to 
2002/03, and cash from 1991/92 to 1999/00 with the latter two grossed-up to Stage 2 RB terms for pre-2002/03. 
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2.2 Input growth 
 
There are various ways of looking at how these funds have been spent.  Table 2 presents data on the 
average number of daily available NHS beds from 1991/92 to 2004/05.  The number of all specialty 
beds fell by 25% between 1991/92 and 2004/05, mostly in those specialties – geriatric, mental illness, 
and learning disability – that have experienced a policy shift designed to move patients out of hospital 
and back into the community.  In contrast, the number of acute beds fell by just 5% over this period and 
has even recorded a small increase since 1999/00.  Day only beds have increased dramatically by 
170%, from 3,400 in 1991/92 to 9,160 in 2004/05, reflecting the move away from overnight stays in 
hospital to day case admissions. 
 
Table 2 Average daily available NHS beds, 1991/92 - 2004/05, England 
 
Year All 
specialties 
Acute Geriatric Mental 
illness 
Learning 
disability 
Maternity Day only 
1991-92 242,677 115,140 42,107 50,278 21,383 13,770 3,399 
1992-93 232,201 112,862 40,346 47,308 18,519 13,167 3,972 
1993-94 219,476 109,713 37,440 43,532 16,269 12,521 4,908 
1994-95 211,812 108,008 36,795 41,827 13,211 11,971 5,699 
1995-96 206,136 108,296 34,328 39,477 12,676 11,358 6,541 
1996-97 198,848 108,869 31,646 37,640 9,693 11,000 6,766 
1997-98 193,625 107,807 30,240 36,601 8,197 10,781 7,125 
1998-99 190,006 107,729 28,697 35,692 7,491 10,398 7,568 
1999-00 186,290 107,218 27,862 34,173 6,834 10,203 7,938 
2000-01 186,091 107,956 27,838 34,214 6,316 9,767 8,155 
2001-02 184,871 108,535 28,047 32,783 5,694 9,812 8,036 
2002-03 183,826 108,706 27,973 32,753 5,038 9,356 8,544 
2003-04 184,019 109,793 27,454 32,252 5,212 9,309 8,813 
2004-05 181,784 109,505 26,619 31,667 4,899 9,095 9,160 
NB The all specialty total excludes day only beds.   
Source: Department of Health (see http://www.performance.doh.gov.uk/hospitalactivity/ 
data_requests/beds_open_overnight.htm). 
 
One cause of cancelled operations in the NHS is the sudden non-availability of a bed in a high 
dependency unit for a patient who needs one (King’s Fund, 2005).  The shortage of adult ‘critical care’ 
beds – which are intensively staffed and expensive to maintain – has been an important bottleneck in 
the NHS.  However, the number of such beds –  both intensive care and high dependency – has 
increased by 44%, from 2,240 in March 1999 to 3,233 in January 2006  
 
Table 3 reports the number of directly employed full-time equivalent NHS staff.  Between 1992/93 and 
1999/00 the total number of staff increased by less than 1% but the number of doctors rose by almost 
20% as did the number of qualified scientific, technical and therapeutic (STT) staff.  Between 1999/00 
and 2004/05, staff numbers increased by 23% with the number of doctors and STT staff increasing by a 
similar amount.  However, these figures underestimate the number of people providing NHS services, 
as they exclude agency staff and staff employed by the private sector to provide contracted out 
services.2 
 
Table 4 provides a breakdown of the ‘all doctors’ total in Table 3.  It shows that between 1999/00 and 
2004/05 the number of full-time equivalent doctors increased by 23% while the number of consultants 
increased by 31% but the number of General Medical Practitioners rose by less than 10%. 
 
 
                                                 
2 In 2004-05 the NHS spent just under £1.45 billion on agency staff, which accounted for 5 per cent of the total NHS spend on pay 
in England. 
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Table 3 NHS staff, by category, full-time equivalents, 1992/93 - 2004/05 
 
Year Total staff Doctors Qualified 
nurses 
Qualified 
STT staff 
Ambulance 
staff 
Clinical 
support 
NHS 
infra-structure 
Practice 
staff nes 
1992/93 866606 74521 265382 72649 14509 n/a n/a 41899 
1993/94 848053 76124 259645 73092 14248 n/a n/a 44347 
1994/95 835034 76840 255037 74050 14560 n/a n/a 42734 
1995/96 842310 80064 256567 76394 13728 211395 150207 49510 
1996/97 848104 81783 257891 80273 13942 215122 144450 49497 
1997/98 846298 84758 256093 81601 14193 215129 141637 50497 
1998/99 855129 86594 257597 84560 14116 220331 139469 50973 
1999/00 873547 88693 261340 86837 14129 226585 142071 52398 
2000/01 892620 90638 266987 89632 14104 234683 144048 51872 
2001/02 931048 92910 277334 93085 14255 249198 149598 53835 
2002/03 978376 97415 291285 98397 14978 262671 158026 55110 
2003/04 1027284 102344 304892 102912 15355 277178 167916 56173 
2004/05 1071462 109483 315440 108585 16587 284394 178098 58443 
NB Clinical support includes assistants, administrative staff working in clinical areas (eg medical records), and porters.  NHS 
infrastructure staff includes central (personnel, finance, IT, legal); hotel, property and estates; managers; and some GP practice 
staff (physiotherapists, practice managers). 
Source: Department of Health (see  http://www.dh.gov.uk/PublicationsAndStatistics/ 
Statistics/StatisticalWorkAreas/StatisticalWorkforce/fs/en). 
 
 
Table 4 Number of doctors (full-time equivalents), by category, 1992/93 - 2004/05 
 
Year Consultants Registrars Others  
training 
Other 
doctors 
GMPs All doctors 
1992/93 15696 10077 14857 4625 27299 74521 
1993/94 16044 10357 15375 4973 27387 76124 
1994/95 16537 10592 15546 4864 27495 76840 
1995/96 17900 10842 16523 5267 27489 80064 
1996/97 18603 10717 17348 5590 27550 81783 
1997/98 19661 11336 18251 5882 27660 84758 
1998/99 20432 11559 18532 6399 27848 86594 
1999/00 21410 12085 18414 6736 28033 88693 
2000/01 22186 12199 19006 7134 28154 90638 
2001/02 23064 12629 19376 7560 28439 92910 
2002/03 24756 13031 20901 8183 28740 97415 
2003/04 26341 13989 22413 8337 29777 102344 
2004/05 28141 16112 24542 8596 30762 109483 
NB Other doctors includes equivalent grades in the community and in public health. 
Source: Department of Health (see http://www.dh.gov.uk/PublicationsAndStatistics/ 
Statistics/StatisticalWorkAreas/StatisticalWorkforce/fs/en). 
 
 
Table 5 provides details of the number of imaging and radio-diagnostic tests undertaken by the NHS in 
England.  There have been marked increases in the number of CT and MRI scans: these have 
increased by 57% and 61% respectively between 1999/00 and 2004/05 although there were also 
substantial increases between 1995/96 and 1999/00 (of 28% and 62% respectively).  
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Table 5 Number of imaging and radio-diagnostic tests by type of test, 1995/96 - 2004/05 
 
Year X-Rays CT scans MRI scans Ultrasound Radio-isotopes Fluoroscopy Total 
1995-96 18,503,844 1,709,244 347,817 4,031,292 467,916 1,077,914 26,138,027 
1996-97 19,167,629 1,056,365 394,940 4,456,816 506,412 1,232,795 26,814,957 
1997-98 19,474,590 1,172,656 473,074 4,790,532 722,096 1,179,979 27,812,927 
1998-99 19,876,933 1,254,474 522,138 5,018,434 699,654 1,244,632 28,616,265 
1999-00 19,967,296 1,359,852 585,797 5,255,330 727,255 1,256,965 29,152,499 
2000-01 19,913,022 1,488,752 632,594 5,382,582 539,141 1,253,847 29,209,938 
2001-02 19,806,876 1,625,304 705,706 5,571,979 537,653 1,222,296 29,469,814 
2002-03 19,512,924 1,767,791 786,646 5,635,358 551,423 1,295,639 29,549,781 
2003-04 20,056,669 1,992,826 857,550 5,937,383 582,742 1,221,102 30,648,272 
2004-05 19,818,330 2,141,652 944,935 6,029,104 560,337 1,190,487 30,684,845 
Source: Department of Health (see 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/imaging_and_radiodiagnostics.htm). 
 
 
Table 6 GP consultations, A&E and outpatient attendances, and inpatient admissions, 1991/92 - 
2004/05  
 
Year GP 
consultations  
(millions) 
New A&E 
attendances 
(thousands) 
First 
outpatient 
attendances 
(thousands) 
Inpatient 
admissions, 
general and 
acute 
(thousands)
Emergency 
admissions, 
general and 
acute 
(thousands)
Elective 
admissions,
general and 
acute 
(thousands) 
Overnight 
cases, 
general and 
acute 
(thousands) 
Day cases, 
general and 
acute 
(thousands) 
1991/92 214 11035 8942      
1992/93 232 10993 9342      
1993/94 252 11365 9681      
1994/95 224 11943 10363      
1995/96 235 12462 10989      
1996/97 254 12484 11294 7924 3598 4327 1731 2596 
1997/98 n/a 12794 11529 8141 3729 4412 1677 2735 
1998/99 217 12811 11778 8676 3849 4827 1738 3089 
1999/00 n/a 13167 12136 8778 3887 4891 1712 3179 
2000/01 221 12953 12466 8944 3943 5001 1700 3301 
2001/02 218 12901 12613 8997 3961 5036 1662 3374 
2002/03 243 13253 12879 9269 4007 5262 1684 3578 
2003/04 215 14080 13341 9719 4274 5445 1734 3711 
2004/05 n/a 14903 13370 10050 4497 5554 1718 3835 
NB The GP consultation data refer to calendar years.  Inpatient admissions are first finished consultant episodes and are on a 
consistent commissioner basis. Source: Departmental of Health, annual Departmental Report (various issues). 
 
2.3 Activity growth 
 
2.3.1 Units of service 
 
Table 6 reports the annual number of GP consultations, new A&E and first outpatient attendances, and 
inpatient admissions from 1991/92 to 2004/05.  Although the number of GP consultations fluctuates 
considerably, there is no discernible trend: the number of consultations in 2003 being virtually the same 
as in 1991.  New A&E attendances have increased by 13% since 1999/00 with first outpatient 
appointments (10%) and inpatient admissions (15%) recording similar increases.  The only dramatic 
change revealed in Table 6 is the relative shift towards day cases (up 21% since 1999/00) and away 
from overnight stays in hospital (no increase since 1999/00). 
 
2.3.2 Drug spending 
 
Apart from staff, the other major item of NHS expenditure is drugs, both in the community and in a 
secondary care (hospital) setting.  Table 7 reports the net annual NHS drugs bill from 1998/99 to 
2004/05.  In 2004/05 the net total bill was just under £10 billion, an increase of just over 40% since 
1999/00 at constant GDP prices. 
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Table 7 NHS Drugs bill expenditure, 1998/99 - 2004/05, (£million) 
 
Year    NHS net cash expenditure relating to: 
 prescriptions 
dispensed 
in the community 
(£ million) 
medicines 
supplied in a 
secondary care 
setting (£ million) 
total (£ million) 
 
 
cash                    at 1998/99 prices 
1998/99   4,389 1,211 5,550 5,550 
1999/00   4,883 1,369 6,202 6,102 
2000/01   5,161 1,530 6,691 6,479 
2001/02   5,552 1,740 7,292 6,896 
2002/03   6,209 2,013 8,222 7,542 
2003/04   6,799 2,308 9,107 8,110 
2004/05   7,344 2,493e 9,837e 8,572e 
NB The figure for medicines supplied in a secondary care setting for 2004/05 is an estimate. It is assumed to be the same 
proportion of total drugs expenditure as it was in 2003/04. 
Source: HC 736-iii (2005, p113) 
 
Table 8 shows that between 1999 and 2005 the number of prescription items dispensed in the 
community increased by 35%, that the average cost per prescription has remained reasonably stable 
(at about £8.50),  The considerable growth in the number of statin prescriptions dispensed in the 
community reflects rapid changes in  practice driven by emerging evidence and government targets. It 
illustrates how dramatic changes can occur within fairly short time periods.   
 
The drugs bill for both community and secondary care combined has consumed between 13% and 14% 
of the NHS budget since 1991 (OHE, 2005, p233). 
 
Table 8 Average cost, number of prescriptions, number of statin prescriptions 
 
Year to September Prescription 
items(millions) 
Average cost per 
prescription item(priced 
as at September 1995) 
Number of statins 
dispensed in the 
community (millions) 
1995 468.3 £7.54 1.1 
1996 482.3 £7.67 1.8 
1997 495.5 £7.93 2.9 
1998 510.5 £8.10 4.5 
1999 523.7 £8.51 6.4 
2000 546.0 £8.78 8.8 
2001 576.9 £8.65 11.7 
2002 610.2 £8.96 15.5 
2003 639.8 £9.12 20.2 
2004 677.5 £9.13 26.4 
2005 711.2 £8.54 32.4 
Source: DH (2005c, p7-8). 
 
2.3.3 Clinical outcomes 
 
Of course, any assessment of a health service ought to examine indicators of the value of its ‘output’, 
pre-eminently the improvement in health outcomes that result from its activities.  Some health outcomes 
indicators are available – such as life expectancy rates, infant mortality rates, and cancer mortality rates. 
However, improvements in these are a function of many factors over which the NHS often has little  
influence. The relative scarcity of readily accessible outcome data specific to the NHS forces any 
analysis to rely heavily on process indicators, on the assumption that they provide a reasonable proxy 
for health outcomes.  This complicates any interpretation of improvements in outcomes (Le Grand, 
2002).  
 
In some areas, the NHS has a more direct influence over hospital death rates, and post-admission and 
post-operative death rates. Four selected conditions/procedures are reported in Table 9.  These rates 
reflect deaths recorded within 30 days of admission or operation.  Death might occur either in hospital or 
after discharge.  They are indirectly age and sex standardised, but are not otherwise adjusted for 
severity.  Since 1998/99 the 30-day death rate following non-elective surgery has declined by 10% (see 
column ‘a’ of Table 9) while the death rate following a first CABG has fallen by one-third (see column ‘c’).  
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The death rate following admission with a stroke is down by 15% (see column ‘d’ of Table 9) but the 
death rate following admission with a fractured femur has increased since 2000/01 after declining in 
1999/00 and 2000/01. 
 
Table 9 Post-operative death rates within 30 days of emergency admission to hospital 
 
Year 
  
Age-sex standardised 30 day death rate per 100,000 admissions: 
 for all surgery, excluding 
cancer 
a 
with fractured femur 
 
b 
for CABG 
 
c 
with stroke 
 
d 
1998/99 5364  10307  2775 30497 
1999/00 5224    9908 2553 28712 
2000/01 5003    9522 2427 27500 
2001/02 4879   9674 2168  26842 
2002/03 4917 10073 2046 26684 
2003/04 4850 10275 1792 25974 
Notes: unit of analysis is a continuous in-patient spell 
(a) deaths within 30 days of surgery, non-elective admissions (for list of eligible operation codes see  http://www.nchod.nhs.uk/) 
(b) deaths within 30 days of admission with fractured proximal femur (comprises ICD 10 codes: S72.0, S72.1, S72.2) 
(c) deaths within 30 days of a first coronary artery bypass graft (OPCS-4 codes: K40-K46) 
(d) deaths within 30 days of admission with diagnosis of stroke (comprises ICD 10 codes: I61-I64) 
Source: NCHOD website (see http://www.nchod.nhs.uk/) 
 
2.3.4 Access  
 
Another dimension of NHS performance concerns how long patients have to wait to access the NHS.  At 
its birth in 1948 the NHS inherited a waiting list of just under 500,000 patients and this queue reached 
an all-time high of 1.3 million patients in 1998.  In early 2000 the Prime Minister committed the 
Government to matching European levels of spending on health care and, later that year, the NHS Plan 
was published (DH: 2000a and 2000b).  This specified several ambitious targets.  First, the 100,000 
reduction in the size of the list was to be maintained but this was to be supplemented by a target for 
maximum inpatient waiting times.  A maximum waiting time of 15 months was to be implemented by 
March 2002, with further reductions to 12 months by March 2003, to 9 months by March 2004, and to 6 
months by December 2005.  
 
Table 10 reports the number of patients awaiting admission at various census dates and how long these 
patients have waited to date.  The figures show that – on this particular measure – NHS Plan targets 
have indeed been met: for example, there are fewer than 1,000 patients still awaiting admission as at 31 
December 2005 and having already waited more than six months.  Less than three years earlier, over 
192,000 patients were waiting longer than 6 months for admission.   
 
 
Table 10 Patients awaiting admission to hospital 
 
Number of patients (000s) awaiting admission having waited: Census 
date  0 - < 3 
months 
0 - < 3 
months 
6 - < 9 
months 
9 - < 12 
months 
12 -<15 
months 
15-<18 
months 
18+   
months  
Total 
(000s) 
2001 521 240  -------------------204 ----------- -------------42 ---------- 0 1 007 
2002 532 262 -------------------219----------- 22 0 0 1 035 
2003 542 258 138 54 0 0 0 992 
2004 577 247 81 0 0 0 0 906 
2005 593 190 1 0 0 0 0 784 
NB The census date is 31 March except for 2005 when it is 31 December. 
Source: Department of Health (http://www.performance.doh.gov.uk/waitingtimes/index.htm). 
 
The NHS Plan also set similar ambitious targets for first outpatient appointments.  A maximum waiting 
time of 26 weeks was to be implemented by March 2002 for all first outpatient appointments, with further 
reductions to 21 months by March 2003, to 17 months by March 2004, and to 13 weeks by December 
2005.  And these targets have indeed been met. 
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2.3.5 Patient experience 
 
Finally, various performance indicators can be constructed from population and patient surveys of 
satisfaction with the NHS.  For example, the regular British Social Attitudes Survey provides information 
on the degree of public satisfaction with various aspects of the NHS.  This is usually an annual survey of 
between 1,700 and 3,500 British adults. 
 
Table 11 reports net satisfaction levels (that is, the percentage of respondents who are satisfied less the 
percentage who are dissatisfied) with five NHS services: GPs, dentists, A&E, outpatients, and 
inpatients.  Of the five services, local GPs are rated the most highly with a net satisfaction rating of over 
50 percentage points in 2004.  However, this is a marked decline from over 70 percentage points in the 
early 1990s.  Net satisfaction with dentists was just under 60 percentage points in the early 1990s.  
However, it has been at about 30 points since then and plummeted to just 4 per cent in 2004, possibly 
due to the well-publicised difficulty of finding an NHS dentist (Appleby and Rosete: 2003 and 2005).  
Satisfaction ratings for A&E are only available since 1999 and these – like those for outpatients – 
declined by about 15 points by 2001.  However, since then satisfaction levels for both A&E and 
outpatients have improved.   
 
The ratings for inpatients mirror those for the NHS as a whole, declining in the 1990s, rising with the 
election of the Labour Government in 1997, but declining after 1999.  Unlike the overall NHS ratings, 
however, there is little sign of an improvement in satisfaction after 2002 with inpatient satisfaction 
reaching an all-time low of just 4% in 2004.   
 
The net satisfaction ratings for outpatients were some 25 points below those for inpatients in the early 
1990s but – with the exception of 2004 – are now only a few points below those for inpatients: ratings for 
the latter have fallen much faster than those for the former.  The net satisfaction ratings for individual 
services exceed those for the NHS as a whole (shown in the final column of Table 11) suggesting that 
respondents answer the two set of questions on a different basis. For example, it may be the case that 
responses to the question about the NHS as a whole are influenced by broader public concerns about 
government performance. 
 
 
Table 11 Public net satisfaction with various NHS services 
 
Year Net satisfaction: % satisfied minus % dissatisfied 
 GP services Dentists A&E Outpatients Inpatients Entire NHS 
1989 68 59 n/a 23 50 -10 
1990 69 58 n/a 23 48 -10 
1991 73 56 n/a 25 51 -1 
1992 n/a n/a n/a n/a n/a n/a 
1993 73 38 n/a 34 50 6 
1994 69 35 n/a 35 42 6 
1995 68 32 n/a 33 40 -8 
1996 65 27 n/a 27 31 -14 
1997 n/a n/a n/a n/a n/a -16 
1998 62 30 n/a 31 37 4 
1999 61 29 28 35 40 13 
2000 61 43 23 34 37 4 
2001 54 29 11 23 27 -2 
2002 54 32 11 26 28 -1 
2003 56 27 13 30 31 7 
2004 54 4 16 32 24 7 
Source: Exley and Jarvis (2003);  Appleby and Rosete (2005) 
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3. Where is the expenditure growth going?    
 
3.1 Main categories of growth   
 
Since 1999/00 NHS spending (in current prices) has increased annually by between about £5-7 billion.  
However, the increased spending has not translated into a corresponding increase in activity.  Of 
multiple contributors to increased spending, key factors  are: workforce pay; escalation of prices in 
drugs and services; and the impact of NICE guidance .   Unless they stimulate extra productivity from 
existing resources, these cost pressures reduce the amount of the budget increase that is available for 
additional activity.  
 
Alongside this extra expenditure, a large programme of reform has been implemented, not least in 
working patterns and contracts for NHS employees.  Relevant employment reforms include: 
• the introduction of the junior doctors’ contract (from December 2000) and compliance 
with the European Working Time Directive (EWTD) by August 2004 
• the re-negotiation of the consultant contract (from November 2003) 
• the re-negotiation of the GMS contract (from April 2004) 
• the application of Agenda for Change to all directly employed NHS staff, except those 
covered by the Doctors’ and Dentists’ Pay Review Body (from December 2004). 
 
In addition to these employment reforms, which have substantially increased NHS costs, some of the 
increase in NHS resources has been consumed by annual pay awards to staff and by increased 
employer pension contributions.  
 
 The price of goods and services purchased by the NHS has also been increasing as has the cost of 
drugs.  On top of these cost pressures, the National Institute for Health and Clinical Excellence (NICE), 
has been preoccupied principally with improving the clinical and cost effectiveness of drugs and medical 
procedures employed in the NHS and its recommendations have been largely cost increasing (Oliver, 
2005). 
 
3.2 Department of Health estimates 
 
The DH provides its own estimate of the extent of the cost pressures and how much has been available 
for additional activity in the form of a ‘high-level breakdown’ of how the extra funding for the NHS has 
been spent, as summarised in Table 12.  Additional resources over the four year period have totalled 
almost £23 billion, at an average of £5.7 billion per year, with on average about: 
• 7% consumed by increased prices and negligence costs 
• 33% spent on pay 
• 18% used to fund additional capital expenditure and staff training, and  
• 43% for extra staff, activity and drugs.   
Table 12 High-level expenditure breakdown of the additional NHS funding  
 
 2001/02 2002/03 2003/04 2004/05 
Additional NHS 
resources  
£5 bn £5.2 bn £5.9 bn £6.7 bn 
spent on:     
price rises and 
negligence costs 
10% 7% 6% 5% 
pay 38% 32% 31% 30% 
capital and training 16% 19% 18% 18% 
extra staff, activity, 
drugs 
36% 42% 45% 48% 
Sources: DH, 2002a, p7; DH, 2003, p19; DH, 2004a, p35; DH, 2005a, p44. 
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Given the relatively large size of the ‘extra staff, activity and drugs’ category, it is useful to examine 
separate figures for each of the three component categories, which are available for 2004-05 (DH, 
2005a, p45).  Of the extra £6.7 billion: 
• £2 billion (30%) was spent on pay rises for existing staff 
• £1.15 billion (18%) was spent on training (increasing the medical school intake) and 
capital (building new hospitals) 
• £335 million (5%) was used to meet the increased cost of goods and services 
purchased; and 
• £3.2 billion (48%) went on extra staff, activity and drugs. 
The £3.2 billion on extra staff, activity and drugs can be broken down as follows: 
• £1.4 billion on additional staff  ( calculate % of total0and,  
• £0.8 billion on increased prescribing. ( s/a) 
 
This leaves just £1 billion out of the additional £6.7 billion for additional activity (DH, 2005a, p45). 
 
3.3 Interpretation of expenditure growth 
 
However, even with this additional breakdown it is not clear how these figures should be interpreted.  
First, the categories presented in Table 12 are a mix of inputs and outputs (e.g., extra staff and activity) 
and this will lead to double counting as the extra staff will be responsible for some extra output.  It is not 
clear how the ‘extra activity’ component of ‘extra staff, activity and drugs’ has been calculated and 
whether it is a residual after all other cost pressures have been met.  
 
Second, the interpretation of the additional resources allocated to pay category is unclear.  In the case 
of goods and services purchased by the NHS it is possible to argue that the NHS is forced to pay the 
market rate for the items it buys and has little influence over the prices it pays; and according to Table 9 
these prices have increased by about 7% on average per year.  However, for many categories of staff 
employed by the NHS (doctors, nurses, scientific and therapeutic staff) the NHS is a virtual monopsony 
buyer and therefore (at least to some extent) able to control the ‘price’ it pays for labour.  With pay levels 
absorbing one-third of the increase in additional funding – and directly controlled by the NHS – is it 
appropriate to subtract this amount from the total available to obtain an estimate of the amount available 
for extra activity?  Some argue that the whole point of the additional pay made available to fund Agenda 
for Change and the new consultant/GP contracts is to re-structure employment practice within the NHS 
to facilitate increased activity.  In this scenario, it is less obvious that all of the additional costs of these 
employment reforms detract from the resources available for extra activity. Indeed, the employment 
reforms described at the start of this section were in part designed precisely to secure productivity 
gains. 
 
A similar interpretation is offered by the NHS Confederation.  It argues that the additional expenditure 
on pay is ‘a crucial part of the NHS reform programme.  High quality patient care can only be delivered 
by valued and motivated staff who are paid a decent wage.  Savings are made in the long term as 
recruiting and retaining skilled staff becomes easier....The reform of contracts and pay for NHS staff has 
increased costs but has been a key step to creating a modern flexible workforce’ (NHS Confederation, 
2005, p2).  The argument is that pay reforms have a direct impact on patient care:  
• more patients are treated more quickly because the new contracts require staff to have 
more flexible working patterns so that increased availability and more highly skilled staff 
can offer prompt diagnosis and treatment 
• patients receive higher quality care as the pay reforms should lead to higher average 
knowledge and skill levels and a reduction in both adverse incidents and patient 
complaints due to poor standards of service. 
 
The data in Table 12 relate to all NHS expenditure. Similar information on where extra future funding is 
expected to go is available for the Hospital and Community Health Services (HCHS) budget alone, 
which accounts for about two-thirds of the total NHS budget.  DH (2005d) reports the inflation uplift 
applied to those patients whose care is priced according to the Payment by Results national tariff for 
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2004-05 and DH (2006) contains similar information for 2005-06 and 2006-07.   These publications 
indicate the additional costs imposed by Agenda for Change, NICE guidance, and the new consultant 
contract, as summarised in Table 13.  The single most costly item has been Agenda for Change, which 
is imposing average annual additional costs of over £500 million. 
 
Table 13 Additional costs imposed by various policy initiatives 
 
                                             Estimated cost increase over previous year’s baseline (£ million) 
 2004/05 2005/06 2006/07 
Agenda for change 490 460 635 
NICE appraisals 304 389 291 
Consultant contract   49 140 50 
Sources: DH (2005d), DH (2006)   
 
Summary data for all HCHS cost pressures are presented in Table 14.  This shows that, in 2004-05, the 
baseline allocation for HCHS increased from 2003-04 by £5.085 billion, from £41.077 billion to £46.162 
billion.  Most of this increase (almost 80%) was allocated to meet various cost pressures, such as 
increased pay and new employment contracts for consultants and other NHS staff.  More precisely, pay 
and pensions absorbed 56% of the extra £5.085 billion allocation with drugs’ costs. NICE 
recommendations, intended to stimulate better health outcomes, absorbed a further 10%. 
 
With unit cost pressures absorbing £3.991 billion, this left £1.094 billion in cash for extra services.  
Unspecified ‘efficiency savings’ were assumed to generate a further £411 million so that, assuming that 
all the anticipated efficiency savings were forthcoming, £1.505 billion was available for additional 
services.  This is a real increase of 3.7% over the 2003-04 baseline allocation of £41.077 billion. 
 
Table 14 HCHS baseline allocations and inflation uplifts, 2004/05 - 2006/07 
 
Financial item 2004-05 
(£ billions) 
2005-06 
(£ billions) 
2006-07 
(£ billions) 
HCHS baseline £46.162 £49.806 £54 289e 
HCHS baseline increase over previous 
year 
£  5.085 £  4.592 £  4.483 
   for cost pressures    
pay (and pensions) £  2.872  £  1.860 £  1.763 
non-pay inflation (prices) £  0.219 £  0.209 £  0.253 
clinical negligence costs £  0.183 £  0.135 £  0.141 
drugs and NICE  £  0.494 £  0.602 £  0.578 
capital costs £  0.223 £  0.363 £  0.484 
total £  3.991 £  3.169 £  3.219 
 
 for other developments (cash) £  1.094  £  1.423 £  1.264 
for other developments (efficiency savings) £  0.411 £  0.769  £  1.245 
Sources: DH (2005d); DH (2006) 
NB 1. The 2004-05 data are taken from DH (2005d, p35) while the 2005-06 and 2006-07 data are extracted from DH (2006, p22).  
The HCHS baseline figure for 2004-05 in DH (2006) is £45.214 billion and this has been used to calculate the HCHS baseline 
increase over previous year for 2005-06.  2. The HCHS baseline figure for 2006/07 has been estimated as generating a 9% 
increase on the 2005/06 figure (see King’s Fund, 2006). 
 
 
The situation is similar in 2005/06.  Of the £4.592 billion (10.16%) increase in the baseline HCHS 
allocation, about 69% is expected to be consumed by cost increases with pay accounting for 41% and 
drugs/NICE absorbing 13%.  This leaves £1.423 billion for extra services together with an additional 
£0.769 million expected to be generated from efficiency savings.  Thus of the £4.592 billion (10.16%) 
increase, £2.192 billion is available for additional services.  This is a real increase of 4.8% over the 
2004-05 baseline of £45.214 billion (assuming that all the efficiency gains are realised). 
 
Following the King’s Fund (King’s Fund, 2006), we assume a 9% increase in the HCHS baseline 
allocation for 2006-07.  After all cost pressures have been deducted, this leaves £1.264 billion for 
additional services together with assumed efficiency gains of £1.245 billion.  This is a real increase of 
5.0% (again, assuming that all the efficiency gains are realised). 
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Overall, the baseline increase for additional HCHS activity ranges from: 
• 2.7% (with no efficiency gains) to 3.7% (all gains realised) in 2004/05 
• 3.1% (with no efficiency gains) to 4.8% (all gains realised) in 2005/06 
• 2.5% (with no efficiency gains) to 5.0% (all gains realised) in 2006/07. 
 
These increases, averaging between 2.8% and 4.5%, are considerably less than the real terms 
increase in NHS expenditure shown in Table 1 which averages 5.9% over this three year period.  This 
illustrates how substantial cash increases can be associated with quantitatively less dramatic increases 
in activity levels and offers one explanation for a puzzle that has exercised many commentators on the 
NHS (Le Grand, 2002, p142). 
 
Another explanation has been put forward by the NHS Confederation (2005).  It argues that the NHS 
had very tight financial settlements for much of the 1980s and 1990s and that expenditure growth was 
often less than health care pay and price inflation.  The interim Wanless Report stated that ‘the 
cumulative underspend between 1972 and 1998 has been calculated as £220 billion in 1998 prices.  
Relative to EU average spending on an income weighted basis, the cumulative underspend is £267 
billion’ (Wanless, 2001, p37).  The NHS Confederation (2005) argues that this explains the shortage of 
many types of staff, the poor condition of many buildings, and the low level of investment in equipment.  
The Confederation argues that by 2000 the NHS was running at high rates of activity, beyond what was 
affordable or sustainable, and that a culture had developed in which NHS organisations were expected 
to report that they had ‘broken even’.  This, combined with sustained under-funding, led to many key 
developments being put on hold or scaled back, including:  
• the prescription of new (more expensive) drugs 
• the maintenance of buildings and infrastructure (so that by 2001 the NHS had a 
maintenance backlog of £3.1 billion) 
• the appointment of new consultants 
• the appointment of additional staff to meet growing demand 
• staff training and medical education 
• the purchase of new equipment 
• improvements to buildings. 
 
Consequently recent funding increases, initially earmarked for new projects, have sometimes been 
required to deal with the results of previous under-investment (NHS Confederation, 2005, p5). 
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4. NHS productivity change 
 
Productivity measures, at least in theory, allow organisational performance to be tracked over time and 
provide insight into the central question of “are we getting value for money”?   
 
Productivity, in essence is the volume of outputs divided by the volume of inputs.  Considerable 
research effort has been devoted over the past two years to improving the measurement of NHS 
productivity.  On the output side attention has focussed on incorporating appropriate adjustments for the 
changing quality of NHS outputs, while on the input side the focus has been on the construction of 
appropriate price indices to deflate NHS expenditure on inputs to a constant price basis.   
 
Because varying assumptions and different methods lead to different estimates of output and input 
growth, and hence to different estimates of productivity growth, the ONS has published two reports 
which show how estimated NHS productivity growth varies according to the assumptions made and 
methods used (ONS: 2004, 2006a).  Before outlining these latest figures, the next section illustrates 
how the DH calculated NHS productivity before June 2004.  This establishes the context for the more 
recent work.  
 
4.1 Productivity measurement before June 2004 
 
Before June 2004, NHS productivity was measured in a rather crude fashion.  The measure of outputs 
was based on a cost weighted activity index (CWAI) as explained below, with inputs equal to NHS 
expenditure deflated by an index of NHS costs and prices. The ratio yields a cost weighted efficiency 
index, a proxy for NHS productivity (Pritchard, 2004). The main interest is in the change in this ratio over 
time. 
 
Table 15 Components of the HCHS/FHS Cost Weighted Activity Index pre-June 2004 
 
Category of activity Activities (number) 
2000-01 
Expenditure 2000/01       
£ million 
Spend as a percentage 
of total expenditure (%) 
(a) HCHS activity    
Inpatient and day case 
episodes 
11,872 15,455.1 64.1 
Outpatient, A&E and ward 
attenders 
58,940 4,710.0 19.5 
Regular day patients 5,631 454.0 1.9 
Chiropody 2,248 106.4 0.4 
Family planning  1,273 70.5 0.3 
Screening 4,089 64.4 0.3 
Health visiting 3,298 324.9 1.4 
District nursing 2,505 1,001.3 4.2 
Community psychiatric 
nursing 
564 644.5 2.7 
Community learning 
disability nursing 
56 473.9 2.0 
Dental episodes of care 
(part) 
747 83.5 0.4 
Ambulances 18,790 711.4 3.0 
Total HCHS expenditure  24,100 100 
    
b) Family health services 
activity 
   
GP consultations 358 3,152.0 21.5 
GP prescribing 108 6,733.0 45.8 
Dental services (part) 31 4,445.0 30.3 
Ophthalmic services 11 357.0 2.4 
Total FHS expenditure  14,687 100 
NB Activities are generally measured in terms of episodes, client contacts, and so on, and are measured in various units (1,000s 
etc).  The precise unit of measurement is not specified in the original source. 
Source: Pritchard (2004) 
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Table 15 shows the activity groups employed in the pre-June 2004 CWAI together with their output 
levels and expenditure weights in 2000-01.  The CWAI was calculated as a weighted average of the 
percentage change in the level of each activity.  As Table 15 shows, this CWAI only distinguished a very 
small number of activities and the coarseness of these activity groups – such as all inpatient and day 
case episodes – meant that some very expensive procedures (such as CBAGs) were attributed the 
same weight as other much less expensive operations (such as cataract removals).   Moreover, with a 
single series (the total number of inpatient and day cases) accounting for just under two-thirds of all 
HCHS expenditure, the HCHS activity index was heavily influenced by movements in the count of 
inpatients and day cases. 
 
Although the calculation of this CWAI is relatively straightforward, the literature can be a little confusing 
because some authors report a CWAI for hospital and community health services (HCHS) alone (that is, 
for the first twelve activities listed in Table 15) whereas others report a CWAI for all NHS expenditure 
(that is, for the first twelve activities listed in part (a) of Table 15 together with the four FMS activities 
listed in part (b) of Table 15). 
 
For example, Oliver (2005) reports a CWAI on an annual basis from 1979/80 to 2000/01 and figures for 
1991/92 to 2000/01 are shown in column ‘a’ of Table 16.  In addition, an expenditure index is presented 
in column ‘b’.  This serves as an indicator of the volume of HCHS resource use.  It reflects the value of 
HCHS expenditure adjusted for both NHS pay inflation and the price of goods and services purchased 
by the NHS.  Dividing the CWAI by the expenditures index reveals the amount of HCHS activity per unit 
of expenditure (this is the so-called cost weighted efficiency index: see column ‘c’ of Table 16). 
 
Table 16 Trends in HCHS activity per unit of cost index (% growth) 
 
Year Cost Weighted 
Activity Index 
(% growth) 
Expenditure 
Index 
(% growth) 
Activity per unit of cost 
index (CWEI) 
(% growth) 
1991/92 5.23 2.60  2.6 
1992/93 3.10 3.10  0.0 
1993/94 3.99 1.59  2.4 
1994/95 4.18 1.39  2.8 
1995/96 3.95 1.76  2.2 
1996/97 1.66 1.47  0.2 
1997/98 1.80 2.21 -0.4 
1998/99 2.06 2.95 -0.9 
1999/00 1.08 3.72 -2.5 
2000/01 0.00 4.54 -4.3 
Source: Department of Health cited in Oliver (2005) 
 
Until 1995/96 output – measured using the CWAI – grows at over 4% per annum and, with annual 
expenditure growth of 2%, this generates an average annual improvement in the efficiency index of 2% 
per year.  From 1996/97, output growth slows and reaches zero in 2000/01.  Input growth, however, 
increases and reaches over 4% in 2000/01.  Together, these two developments generate small falls in 
the efficiency index in 1997/98 and 1998/99, with more substantial falls in 1999/00 and 2000/01 (of 
2.5% and 4.3% respectively).   
 
4.2 Developments in NHS productivity measurement since June 2004 
The inadequacies in productivity measures traditionally used in measuring the productivity of public 
services led the National Statistician to commission from Sir Tony Atkinson a review of methods of 
measuring government output and productivity.  The Atkinson Report (2005) contains numerous 
recommendations for improvements, most of which have been accepted by the ONS, and many of 
which relate specifically to the NHS. The ONS has put in place a programme of work to implement the 
Atkinson recommendations, and has produced two articles describing potential enhancements to 
measuring its productivity.  The current state of productivity measurement is described in this section. 
 
4.2.1 Measuring the volume of NHS inputs 
 
Research to improve the measurement of the volume of NHS inputs has focused on three different 
categories: labour, goods and services procured, and capital (ONS: 2004, 2006a).  Two approaches to 
  Value for money in the English NHS: summary of the evidence     15 
 
the conversion of expenditure on NHS inputs into volume measures have been adopted by the ONS 
(2006a): 
• an ‘indirect’ approach deflates NHS expenditure by adjusting labour and procurement 
expenditure by pay and price indices respectively, and capital expenditure is adjusted 
for changes in the rental value of capital; and 
• a ‘direct’ approach which converts NHS staff numbers and earnings weights into a 
volume measure by adjusting for hours worked and taking account differences in 
earnings.  The York/NIESR study adopted an alternative approach which incorporated 
information on skill mix but obtained similar results to those obtained by ONS (2006a, 
p29). 
 
Here, we briefly outline the different ways in which the ONS has estimated the volume of inputs and 
then summarise the impact that these different methods have on the estimated input growth rate.  
 
Labour   
The ‘indirect’ and ‘direct’ methods yielded very similar estimates of the average annual change in NHS 
labour inputs between 1995 and 2004: the indirect method resulted in an average annual growth rate of 
3.4% while the direct method suggested a slightly lower annual growth rate of 3.0%.   
 
Prescription drugs 
The identification of a suitable price deflator for expenditure on drugs dispensed outside hospitals has 
been problematic.  The DH now links the prices of branded and generic drugs so that, when branded 
drugs fall out of patent and much cheaper generic drugs become available, this fall in the cost of similar 
drugs is counted as part of the price change.  This new analysis has only been undertaken for 2003 and 
2004 so that, prior to 2003, two alternative deflators –  the average cost per item and an unlinked 
Paasche price index separately accounting for branded and generic drugs –  are employed, each 
registering very different average annual price changes between 1995 and 2002 (+5.2% and -0.8% 
respectively). 
 
Goods and services purchased by HCHS 
The DH constructs a HCHS Health Service Costs index.  This measures the broad monthly price 
changes associated with its current expenditure on goods and services purchased by HCHS (DH, no 
date).  ONS (2006a) report an average annual growth in this price index of 0.7% per year between 1995 
and 2004. 
 
Capital 
ONS (2006a) presents volume indices for capital consumption (based on depreciation estimates) and 
for capital services provided (based on estimated rental prices for capital stock items).  Between 1995 
and 2004, the average annual growth in capital consumption (3.3%) is slightly less than the growth in 
capital services (4.3%). 
 
Total NHS inputs 
Using the most recent methods and selecting those estimates of the change in the volume of inputs 
which generate the highest and lowest growth rates over the period 1995 to 2004, yields a lowest 
growth rate of 3.9% per year and a highest growth rate of 4.6% per year (4.8% and 5.5% over the period 
1999-2004).  The former is based on: the drugs bill deflated using an average cost of all items; a capital 
input measure based on an estimate of capital consumption; and the direct labour (counting staff) 
method to estimate the growth in the volume of labour. The latter estimate is based on: the drugs bill 
deflated by a Paasche price index; a capital input measure based on an estimate of capital services; 
and the indirect labour method (deflating expenditure on labour using price indices) to estimate the 
volume growth in labour. 
 
4.2.2 Output without quality adjustments  
 
Most research since 2004 has focused on output measurement. Table 17 summarises the CWAI for 
HCHS only (row ‘a’) as reported in Table 16 and compares it with a number of series of HCHS and FMS 
combined produced by Atkinson and the ONS.  The first series (row ‘b’) produced pre-June 2004 shows 
that the total NHS growth exceeds HCHS growth, implying that the FMS output growth rate exceeds 
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that of HCHS. Reporting the HCHS growth rate alone may therefore understate the apparent all NHS 
output growth rate. 
 
Table 17  Estimated NHS output growth rates without any quality adjustments (% per annum) 
 
Output estimation 
method and 
service coverage 
Year 
 
1996 
 
 
1997 
 
 
1998 
 
 
1999 
 
 
2000 
 
 
2001 
 
 
2002 
 
 
2003 
Cumulative 
Total 
1996-2003 
Until May 2004          
a HCHS only 1.7 1.8 2.1 1.0 0.0 n/a n/a n/a n/a 
b HCHS&FMS 2.6 2.3 2.6 2.1 0.9 1.9 2.6 2.6 19.0 
          
June 2004          
c HCHS&FMS 3.9 1.3 1.8 3.1 3.0 4.2 4.1 4.1 28.5 
          
October 2004          
d HCHS&FMS 2.9 1.5 1.8 3.2 3.0 4.2 4.1 4.1 27.6 
          
February 2006          
e HCHS&FMS 3.3 1.5 1.8 3.2 3.0 4.3 3.7 3.7 27.3 
Sources: for row ‘a’, Department of Health cited in Oliver (2005); for rows ‘b/c/d’, Atkinson Review, 2005, p108; for row ‘e’, ONS, 
2006a, p15. 
Note: the average of the annual growth rates will fall slightly short of the cumulative total divided by the number of years.  Although 
Atkinson’s (2005) focus is the UK, the above figures are virtually all for England. 
  
The number of different activities separately identified has increased dramatically: first, from 16 to 1,300, 
and then to 1,600, and now to almost 1,900 different activities (ONS, 2006a).  Instead of a single activity 
category for all inpatient admissions, the new measure distinguishes over 600 elective and 600 
emergency inpatient categories, with each admission allocated to one of about 600 different healthcare 
resource groups (HRGs).  Each admission within a given HRG is expected to consume approximately 
the same volume of resources.   
 
The overall growth rate of any category will reflect the growth in its component parts.  The effect of 
increasing the number of categories is implicitly to adjust in a much more refined fashion for the relative 
difficulty of the tasks being undertaken by the NHS. With only 16 different components, the pre-June 
2004 NHS output growth rate is shown in row ‘b’ of Table 17.  The introduction of 1,300 different 
categories in June 2004 – leading to far more homogeneous activity categories – generates the output 
growth estimates shown in row ‘c’.  The cumulative total growth between 1996 and 2003 using this new 
method is 28.5%, which is 50% greater than the cumulative total growth using the May 2004 (16 output 
categories) estimation method (shown in row ‘b’). 
 
The new output estimation method was subject to some further small improvements and, in October 
2004, the ONS published further output growth estimates.  These estimates are presented in row ‘d’ of 
Table 17.  They differ slightly from those presented in June 2004 but, overall, the cumulative change in 
NHS output over the period 1996-2003 remains at about 28%.  The DH estimated that around three 
quarters by value of all NHS activity was covered by this much extended measure of NHS output (ONS, 
2004). 
 
In February 2006, the ONS published further revised growth estimates.  These are based on 1,900 
different types of NHS activity covering about four-fifths by value of all activity in England.  These 
estimates also include about three-quarters by value of all activity in Northern Ireland and the intention 
is to improve the coverage of these estimates by incorporating data for Scotland and Wales when 
possible.  Despite the refinements incorporated into these latest estimates, the cumulative growth total 
between 1996 and 2003 remains largely unchanged – down only 0.3 percentage points – at 27.3%.  
Applying this new method, estimated output growth for 2004 is 4.8% (ONS, 2006a, p15). 
 
One important point to note about the output growth estimates presented in Table 17 is that they 
incorporate no adjustments for improvements in the quality of output and implicitly assume that 
procedures adopted today offer the same health benefits as the same procedures undertaken 5 or 10 
years ago.  This is unlikely to be the case and considerable research has recently been undertaken to 
incorporate such quality improvements into the output growth estimates. 
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4.2.3 Output with quality adjustments 
 
The Atkinson Review noted that measuring NHS output simply on the basis of countable activities and 
cost-based weights ignores the quality of these activities and the contribution they make to valuable 
outcomes.  Recent research – see the York/NIESR study (Dawson et al, 2005) and the DH response 
(DH, 2005e) – has identified several potential quality adjustment factors.  In brief, the York/NIESR work 
recognises a cluster of interacting factors when arriving at an overall quality adjustment for the 
measurement of NHS output.  These factors include: 
• incorporating improved survival rates for patients 
• incorporating improved health gains for patients (the ‘before’ and ‘after’ change in 
health status) 
• adjusting the above factors for the life expectancy distribution of patients (younger 
patients will enjoy the benefits for longer than older ones) 
• allowing for changes in waiting times (waits may reduce health gains and be stressful in 
their own right) 
 
The York/NIESR study estimates that all these elements increase NHS output growth by an additional 
average of 0.17 percentage points per year over the period 1999/00 to 2003/04.  (This time period was 
the longest for which the relevant data were available for quality adjustments). 
   
Following the Atkinson Review (2005) and the York/NIESR (2005) study, the DH (2005e) has proposed 
four further quality adjustments to the measurement of NHS output.  These factors include: 
• using value weights rather than cost weights where these are very different.  For 
example, the DH estimates that each statin prescription has a marginal benefit of £115 
(in terms of life years saved) but costs £27.  Using £115 instead of £27 as the weight for 
each statin prescription increases overall NHS output growth by, on average, 0.81 per 
cent a year between 1999 and 2004. 
• incorporating improved outcomes from primary medical care.  Data for a full quality 
adjustment based on primary medical care outcomes are still developing.  Meanwhile, 
the DH uses data on improvements in blood pressure and cholesterol control to 
estimate that quality adjustments based on currently available data for primary medical 
care increase overall NHS output growth by 0.16 percentage points per year for the two 
years for which data are available (2002/03 and 2003/04).  
• incorporating improved survival rates from myocardial infarction.  Using data available 
on hospital episodes for patients admitted to hospital with myocardial infarction, the DH 
estimates that, between 1998/99 and 2003/04, the decline in the mortality rate for 
myocardial infarction acute admissions within one year of admission adds 0.01 
percentage points to the annual output growth measure.  
• the suggestion, articulated by the Atkinson Review, that the ONS and DH should 
explore whether measures of quality change over time could be based on the national 
patient survey programme which measures aspects of patient experience.  Hitherto, 
there have been two surveys in four different areas of NHS activity: inpatients, A&E, 
outpatients, and primary care.  The DH estimates that the quality adjustment for patient 
experience increases total NHS output growth by 0.17 percentage points per year 
during 2002/03 and 2003/04.   When averaged over a five year period 1999/00 to 
2003/04 this figure becomes 0.07 percentage points, assuming that there is no change 
in patient experience for the first three years (ONS, 2006a, p25). 
• a ‘value of health’ adjustment based on annual real earnings growth.  The Atkinson 
Review noted that rising real wage rates means that we may attach a higher valuation 
to days lost through sickness and absence today than forty years ago, and that account 
might need to be taken of the increased real value of public services in an economy 
with a rising real GDP.  Gravelle and Smith (2001) argue that the financial value 
attached to a Quality Adjusted Life Year should grow at 1.5 per cent per year in real 
terms to reflect this annual growth in real earnings. 
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Taken together, the addition of the quality adjustments outlined above (but excluding the value of life 
adjustment) increases the average output growth rate for the NHS by an additional 1.18 percentage 
points per annum over the five year period 1999/00 to 2003/04.  The value of health adjustment adds a 
further 1.5 points per year so that the overall quality adjustment effect adds 2.68 percentage points to 
the average annual output growth rate.   
 
These adjustments are added to the basic annual average output growth rate of 3.8 per cent per year 
from 1999/00 to 2003/04 as outlined in row ‘e’ of Table 17.3 For 1999/00 - 2003/04, this yields an 
average output growth rate of: 
• 3.8 per cent without any quality and value of health adjustments 
• 5.0 per cent with only quality adjustments; and  
• 6.5 per cent with both quality and value of health adjustments. 
Clearly some of the adjustments described above are experimental and contentious. They are 
discussed further in section 4.3 below.  
 
4.2.4 Post-June 2004 NHS productivity estimates  
 
Productivity is defined as the ratio of NHS outputs to inputs and, clearly, productivity levels will depend 
on which methods are used to estimate the volume of inputs and outputs.  ONS (2006a) presents 
various productivity estimates, reflecting the different measures of inputs and outputs available and 
these are summarised in Table 18 (see sections 4.2.1 – 4.2.3 above for further details of the various 
input and output estimation methods). 
 
Table 18 Estimated NHS annual average output, input, and productivity growth (%) 
 
Study Time 
period 
Adjustments to 
output 
measure 
Output 
growth 
(%) 
Input growth (%) 
 
min                max 
Productivity growth  
 
min                  max 
ONS (2004) 1995-2003 None 3.1 3.5 4.2 -1.1 -0.4 
ONS (2006) 1995-2004 None 3.2 3.9 4.6 -1.3 -0.6 
ONS (2006) 1999-2004 For quality only 5.0 4.8 5.5 -0.5 0.2 
ONS (2006) 1999-2004 For quality and 
value of health 
6.5 4.8 5.5 0.9 1.6 
Source: ONS (2004; 2006a).  
 
The first set of estimates in Table 18 are for 1995-2003.  The output estimates are based on 1,600 
different categories of activity but incorporate no quality adjustments (ONS, 2004).  With output growth 
averaging 3.1% and input growth varying between 3.5 and 4.2%, NHS productivity growth falls between 
-0.4% and -1.1% per year. 
 
The second set of estimates in Table 18, from ONS (2006a), are for 1995-2004.  These incorporate 
various refinements to the measure of inputs and outputs over the first set of estimates, but no quality 
adjustment in the measure of output growth.  The latest ONS estimate is that, for 1995-2004 (not taking 
account of quality change), NHS productivity fell by an average of between -0.6% and -1.3% per year. 
 
The third set of estimates incorporate the quality adjustments proposed in the York/NIESR and DH 
studies, but with no allowance for the increasing value of health.  These quality adjustments are not 
available for 1995 to 1998 so the figures reported in Table 18 are for the shorter (five year) period, 1999 
to 2004.  Over this period NHS productivity grew between  
-0.5% and 0.2% per year.   
 
                                                 
3 Strictly speaking the average is 3.6 % but the use of a different baseline for unit costs and other minor changes increases this to 
3.8% (ONS, 2006a, p16). 
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Adding an adjustment for the increasing value of health boosts the estimated output growth rate to 6.5% 
per year and, with an input growth rate of between 4.8% and 5.5%, this yields an NHS productivity 
growth rate of between 0.9% and 1.6% per year over the five year period, 1999 to 2004 (see the final set 
of estimates in Table 18). 
 
4.3 Summary 
 
Until recently, NHS productivity was calculated in a rather simplistic fashion.  Output growth was 
estimated as a weighted average of the growth in sixteen very broad categories  (such as all inpatient 
admissions and all outpatient/A&E/ward attendances).  This very coarse categorisation ignored the 
heterogeneity within each category, for example the very large variations in costs and benefits amongst 
hospital inpatient admissions. Moreover, even if such heterogeneity could be accommodated, simply 
counting the numbers in each category implicitly assumed that quality remained unchanged across 
years. 
 
Since June 2004, the number of separately identified activity categories has increased dramatically. 
This implicitly secures some adjustment for changes in case mix, and reduces the importance of patient 
heterogeneity. It is likely to have secured a major improvement in the accuracy of output measures.  
 
Furthermore, some attempt has been made to generate estimates of ‘quality’ change within categories.  
Quality in health care has two principal connotations: the extra length and quality of life secured by 
medical intervention, and the personal responsiveness of the health system, independent of any health 
gain it bestows. Although there has been some attention to reduced waiting times (assumed to be a 
major aspect of responsiveness in the UK), the main effort in productivity measurement to date has 
been on the ‘health gain’ element of NHS outputs. Attempts have been made to capture changes in the 
extra life years secured within each treatment category using two broad approaches: changes in the 
mortality associated with each intervention, and changes in the age profile of patients. Improved 
post-treatment mortality secures self-evident health gains. However, it is also likely that health gains will 
increase as the age of patients decreases, as the gains will be spread over a longer lifetime. Recent 
methodological changes therefore seem reasonable in assuming that, other things equal,  productivity 
will decline if the age of patients increases. 
 
However, much remains to be done to improve output methodology. Most notably, the assumption that 
the health gains associated with each activity are proportionate to its average costs is manifestly wrong. 
Instead, in principle, each activity should be weighted by the average health gain it bestows. The 
Department of Health has recognized this by arguing for a much higher weight to be attached to statin 
prescriptions than their costs, reflecting the relatively high cost-effectiveness of the intervention. 
However, to be consistent, this principle should be applied to all interventions, including those that 
confer few health gains. In short, the statin methodology is a step in the right direction, but will offer a 
balanced view of productivity changes only if it is applied across all interventions. 
 
Other criticisms of the quality adjustments have been made: for example, the use of value rather than 
cost weights for statin prescriptions attributes this benefit to the NHS whereas it could be argued that 
this should be attributed to the pharmaceutical industry.   
 
The application of the ‘value of life’ adjustment has stimulated much debate and remains controversial.  
It should be noted that the annual 1.5% value of life adjustment has a major impact on estimated 
productivity growth. However, no consensus has yet emerged over whether the NHS should be credited 
with this value of life adjustment, and there are strong arguments against this approach, for example: 
• the value of life adjustment reflects a price change whereas productivity measurement is 
usually based on the measurement of quantities (of inputs and outputs) 
• the NHS is neither responsible for nor has any control over real earnings growth in the rest of 
the economy and therefore should not be credited with it. 
 
The ONS is currently initiating a debate on this topic. 
 
On the responsiveness aspect of quality, some work has now been carried out to incorporate changes 
in waiting times into the output measure. This is exploratory, and has so far yielded little change to 
productivity estimates. This is not surprising, as waiting times apply to only a subset of NHS activity, and 
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in any case average waiting times have until recently not changed markedly. Rather, the policy priority 
has been to focus on the relatively small number of very long NHS waits, the elimination of which is 
unlikely to affect productivity measures materially.  
 
Alongside the developments on the output side, improvements have also been made to the calculation 
of the volume of NHS inputs.  These are mainly technical in nature, but some quantitatively important 
issues remain unresolved, such as the method of deflating NHS expenditure on pharmaceuticals. 
 
Between 1997/98 and 2000/01 the old cost weighted efficiency index declined by, on average, 2% per 
annum but the most recent estimates of productivity growth - incorporating quality and value of life 
adjustments - suggest an average annual improvement in productivity of between 0.9% and 1.6% since 
1999/00.  However, to criticise the ONS for outlining the issues involved and encouraging public debate 
about the measurement of NHS productivity seems to miss the point (The Economist, 4 March 2006).  
For the moment we have to accept that there is no definitive measurement of NHS productivity and that, 
with various figures available, commentators will either acknowledge this uncertainty and cite the 
various estimates available or choose that measure which supports their argument and ignore the 
others. We feel that the appropriate way forward is to have a well-informed and wide-ranging debate on 
the topic in order to identify the main priorities for methodological clarification. 
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5. Conclusion 
 
Since 1999/00 the NHS has enjoyed relatively large funding increases together with a reform 
programme – particularly in terms of staff contracts and working patterns – intended to create a more 
patient-led organisation capable of delivering a service that approaches the best in the world.  In this 
context, it is important to remember that, for many years, the UK has spent far less on health care (as a 
proportion of its GDP) than most of its European neighbours and that this may well have contributed to 
poor UK health outcomes (e.g., in terms of cancer survival rates) relative to comparable continental 
European performance levels (Wanless, 2001).   
 
The period between 1999/00 and 2004/05 has given rise to the following changes: 
• annual real increases in NHS resources of about 7%  
• NHS staff numbers increased by 23%, including a 31% increase in consultants 
alongside an increase in the number of General Medical Practitioners of less than 10%. 
• Changes to inpatient hospital use 
o the number of inpatients awaiting admission declined by over 300,000 
o inpatient admissions increased by between 10% and 15% 
o NHS bed distribution changed; the number of all specialty beds fell by almost 
5,000 (largely in geriatrics, mental illness and learning disability) but the 
number of acute beds increased by over 2,000 and the number of critical care 
beds by almost 1,000. 
• New A&E attendances and first outpatient appointments increased by between 10% 
and 15% 
• The number of GP consultations remained largely unchanged 
• There were marked increases in the number of CT scans (up 57%) and MRI scans (up 
61%) 
• Drug spending increased by 40%, with the number of prescriptions dispensed in the 
community up by 35% 
• In terms of the quality of NHS care: 
o post-admission and post-operative mortality rates have generally declined 
o emergency re-admission rates have risen over the past three years  
• Surveys of public opinion provide a mixed picture of the performance of the NHS. 
 
If Wanless’ estimate of a cumulative underspend between 1972 and 1998 of £267 billion in 1998 prices 
is accurate, it is unlikely that an additional £6 billion per annum will transform the NHS in the space of 
five or six years.  Some of the additional resources could be seen as investment in labour and capital 
needed to overcome the years of under-investment.  Many view the recent major increases in pay levels 
in this light.  On the capital side, the downward trend in the number of acute beds has been reversed 
and there has been dramatic growth in the number of day beds.  Moreover, hospital activity levels are 
increasing, though not in proportion to the funding increases.  One reason for this is that the new 
consultant and GMS contracts, as well as Agenda for Change, have consumed a significant percentage 
of the funding increase.  Varying perspectives have emerged regarding the merits of these initiatives, 
ranging from the benign view that they are investments in human capital that will lead to future 
productivity gains, to the jaundiced view that the increased investment is failing to show commensurate 
benefits and was at unnecessarily high levels. 
 
Additional cost pressures have also been imposed by NICE recommendations, the hospital building 
programme, and a considerably increased intake in medical schools.  Whether these will lead to 
measurable health gains is also a matter for debate.  However, in the short term, once these cost 
pressures have been met, much less is available for increased activity, the prime driver of the NHS 
output measures.  
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Finally, this report has described the recent concerted attempts that have been made to refine the 
measurement of NHS productivity, most especially on the output side. However, there remain many 
important unresolved issues, which include the proper treatment of both physical and human capital 
inputs, the measurement of health care quality, handling of ‘hard to measure’ areas, such as mental 
health, and the treatment of pharmaceutical price changes. These and other technical issues suggest a 
challenging agenda for analysts over the coming years. Yet it is becoming clear that the careful 
measurement of productivity growth plays a central role in deciding how much of taxpayers’ money to 
spend on health care, and in holding the NHS to account for its spending. The pursuit of better 
measurement of Value for Money therefore has a central role in informing public debate. 
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